A look into the future: improving diabetes care by 2015

Abstract Insulin initiation, which was traditionally the province of specialists, is increasingly undertaken by primary care. However, significant barriers to appropriate and timely initiation still exist. Whilst insulin is recognized as providing the most effective treatment in type 2 diabetes, it is also widely considered to be the most challenging and time consuming. This editorial identifies that the organization of existing healthcare services, the challenges faced by patients, and the treatments themselves contribute to suboptimal insulin management. In order to improve future diabetes care, it will be necessary to address all three problem areas: (1) re-think the best use of existing human and financial resources to promote and support patient self-management and adherence to treatment; (2) empower patients to participate more actively in treatment decision making; and (3) improve acceptance, persistence and adherence to therapy by continuing to refine insulin therapy and treatment regimens in terms of safety, simplicity and convenience. The principles discussed are also applicable to the successful management of any chronic medical illness.

[1]  G. Booth,et al.  Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Methods. , 2013, Canadian journal of diabetes.

[2]  M. Davies,et al.  Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy , 2011, Diabetes, obesity & metabolism.

[3]  A. Strömberg,et al.  Which Interventions are Used by Health Care Professionals to Enhance Medication Adherence in Cardiovascular Patients? A Survey of Current Clinical Practice , 2011, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[4]  S. Amiel,et al.  Hypoglycaemia: current management and controversies , 2011, Postgraduate Medical Journal.

[5]  Heleen Riper,et al.  Web-Based Depression Treatment for Type 1 and Type 2 Diabetic Patients , 2011, Diabetes Care.

[6]  K. Khunti,et al.  Clinical inertia in management of T2DM. , 2010, Primary care diabetes.

[7]  D. Cherry,et al.  National Ambulatory Medical Care Survey: 2007 summary. , 2010, National health statistics reports.

[8]  J. Davidson New injection recommendations for patients with diabetes. , 2010, Diabetes & metabolism.

[9]  R. Chapman,et al.  The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  T. Koepsell,et al.  All-Cause Mortality Risk Among a National Sample of Individuals With Diabetes , 2010, Diabetes Care.

[11]  D. Cherry,et al.  Population aging and the use of office-based physician services. , 2010, NCHS data brief.

[12]  E. Gale,et al.  Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007 * , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[13]  D. Drotar,et al.  Interventions With Adherence-Promoting Components in Pediatric Type 1 Diabetes , 2010, Diabetes Care.

[14]  J. Dale,et al.  Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study. , 2010, Primary care diabetes.

[15]  S. Jacob,et al.  Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap? , 2010, Advances in therapy.

[16]  M. Martinell,et al.  Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes. , 2010, Diabetes & metabolism.

[17]  Trudy van der Weijden,et al.  Primary care nurses struggle with lifestyle counseling in diabetes care: a qualitative analysis , 2010, BMC family practice.

[18]  G. Verbeke,et al.  Start improving the quality of care for people with type 2 diabetes through a general practice support program: a cluster randomized trial. , 2010, Diabetes research and clinical practice.

[19]  K. Dahl-Jørgensen,et al.  The establishment of a new national network leads to quality improvement in childhood diabetes: Implementation of the ISPAD Guidelines , 2010, Pediatric diabetes.

[20]  S. Bolge,et al.  Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. , 2010, Diabetes research and clinical practice.

[21]  R. Rubin,et al.  Correlates of Insulin Injection Omission , 2010, Diabetes Care.

[22]  E. Ford,et al.  Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.

[23]  L. Edwall,et al.  The meaning of a consultation with the diabetes nurse specialist. , 2009, Scandinavian journal of caring sciences.

[24]  H. Rodbard,et al.  Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[25]  F. Snoek,et al.  Barriers to insulin initiation and intensification and how to overcome them , 2009, International journal of clinical practice. Supplement.

[26]  J. DeVries,et al.  Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes , 2009, Diabetologia.

[27]  Allison Hedley Dodd,et al.  Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004* , 2009, Current medical research and opinion.

[28]  P. Raskin,et al.  Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets ‐ the TITRATETM study , 2009, Diabetes, obesity & metabolism.

[29]  V. Woo,et al.  Important differences: Canadian Diabetes Association 2008 clinical practice guidelines and the consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2009, Diabetologia.

[30]  G. Rutten,et al.  Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands. , 2009, Primary care diabetes.

[31]  W. Hsu Consequences of Delaying Progression to Optimal Therapy in Patients with Type 2 Diabetes Not Achieving Glycemic Goals , 2009, Southern medical journal.

[32]  Vicki S Conn,et al.  Meta-analysis of Quality of Life Outcomes Following Diabetes Self-management Training , 2008, The Diabetes educator.

[33]  N. Marchionni,et al.  Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. , 2008, Diabetes research and clinical practice.

[34]  G. Nocea,et al.  Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) study , 2008, Diabetes, obesity & metabolism.

[35]  E. Loveman,et al.  The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. , 2008, Health technology assessment.

[36]  Sandra van Dulmen,et al.  Furthering patient adherence: A position paper of the international expert forum on patient adherence based on an internet forum discussion , 2008, BMC health services research.

[37]  S. Gough,et al.  Delayed initiation of subcutaneous insulin therapy after failure of oral glucose‐lowering agents in patients with Type 2 diabetes: a population‐based analysis in the UK , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[38]  Gretchen A. Piatt,et al.  Patients with Complex Chronic Diseases: Perspectives on Supporting Self-Management , 2007, Journal of General Internal Medicine.

[39]  J. Lasalle,et al.  The team approach to diabetes management: partnering with patients , 2007, International journal of clinical practice. Supplement.

[40]  J. Selam,et al.  The usage of a simplified self‐titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE™ 303 study , 2007, Diabetes, obesity & metabolism.

[41]  T. Pieber,et al.  Refining basal insulin therapy: what have we learned in the age of analogues? , 2007, Diabetes/Metabolism Research Reviews.

[42]  A. Morris,et al.  Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. , 2007, QJM : monthly journal of the Association of Physicians.

[43]  N. Freemantle,et al.  Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. , 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

[44]  H. Vinod,et al.  Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[45]  H. Brenner,et al.  Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study , 2006, BMC family practice.

[46]  Michael J. Pencina,et al.  Trends in the Incidence of Type 2 Diabetes Mellitus From the 1970s to the 1990s: The Framingham Heart Study , 2006, Circulation.

[47]  T. Davis,et al.  Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study , 2006, The Medical journal of Australia.

[48]  B. Bolinder,et al.  Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002. , 2006, Clinical therapeutics.

[49]  S. Harris,et al.  Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). , 2005, Diabetes research and clinical practice.

[50]  W. Polonsky,et al.  Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. , 2005, Diabetes care.

[51]  R. Rubin,et al.  Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[52]  Curtiss B. Cook,et al.  Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting , 2005, The Diabetes educator.

[53]  Robert J. Stroebel,et al.  Adapting the Chronic Care Model to Treat Chronic Illness at a Free Medical Clinic , 2005, Journal of health care for the poor and underserved.

[54]  M. Davies,et al.  Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. , 2005, Diabetes care.

[55]  R. Rubin,et al.  Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. , 2005, The American journal of medicine.

[56]  R. Rubin,et al.  Type 2 diabetes: the role of insulin. , 2005, The Journal of family practice.

[57]  L. Phillips,et al.  Patient Adherence Improves Glycemic Control , 2005, The Diabetes educator.

[58]  J. Cramer A systematic review of adherence with medications for diabetes. , 2004, Diabetes care.

[59]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[60]  T. Skinner,et al.  Discrepancies between patient and professionals recall and perception of an outpatient consultation , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[61]  C. Greaves,et al.  Converting to insulin in primary care: an exploration of the needs of practice nurses. , 2003, Journal of advanced nursing.

[62]  俊郎 黒木,et al.  Centers for Disease Control and Prevention (CDC) ホームページの活用法 , 2002 .

[63]  H. Mcdonald,et al.  Interventions to enhance patient adherence to medication prescriptions: scientific review. , 2002, JAMA.

[64]  K. Hardy,et al.  Information given to patients before appointments and its effect on non-attendance rate , 2001, BMJ : British Medical Journal.

[65]  Jennifer Y. Liu,et al.  Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. , 2001, The American journal of medicine.

[66]  K. Khunti,et al.  Who looks after people with diabetes: Primary or secondary care? , 2000, Journal of the Royal Society of Medicine.

[67]  S. Haffner,et al.  Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.

[68]  J. L. Botha,et al.  Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices , 1998, BMJ.

[69]  J. Probstfield,et al.  Examination of medical professions for counseling on medication adherence. , 1985, The American journal of medicine.

[70]  L. Morlock,et al.  Patient Understanding and Satisfaction as Predictors of Compliance , 1983, Medical care.

[71]  Guidelines Task Force Clinical Global guideline for type 2 diabetes , 2012 .

[72]  M. Godwin,et al.  Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: a study of primary care practices in St John's, Nfld. , 2010, Canadian family physician Medecin de famille canadien.

[73]  Wolters Kluwer,et al.  Medication Non-Adherence in the Elderly: How Big is the Problem? , 2008 .

[74]  E. Kilpatrick,et al.  Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes. , 2008, Current medical research and opinion.

[75]  UK Prospective Diabetes Study Group Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration , 2007, Diabetologia.

[76]  M. Burge,et al.  Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. , 2004, Drugs & aging.

[77]  M. Burge,et al.  Hypoglycaemia in Elderly Patients with Diabetes Mellitus , 2004 .

[78]  S. Hoermann The national ambulatory medical care survey. , 1973, Medical care.